ArriVent BioPharma, Inc.

Q1 2026 13F Holders

Symbol
AVBP
CUSIP
04272N102
Type
Equity
Class
COM
Num filers
140
Total reported value, excl. options
$969M
Manager Report Date Value ($000) Shares